Preparation method of ruthenium-based covalent organic framework material, antibacterial gel electrochemical luminescent device and application

By combining ruthenium-based covalent organic framework materials with antibacterial gel, antibacterial gel electrochemiluminescent devices were prepared, which solved the problem of miniaturization and penetration depth of electrochemiluminescent devices in medical applications, and achieved a deeper antibacterial Effects and wearable devices applications.

CN118909268AActive Publication Date: 2024-11-08HUBEI UNIV

Patent Information

Application Number
CN202410967910.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08
Estimated Expiration
2044-07-18

AI Technical Summary

Technical Problem

In therapeutic applications, existing electrochemiluminescent devices have difficulties in miniaturization of equipment, limited penetration depth of light source and limited driving mode, making it difficult to achieve accurate and controllable medical applications.

Method used

Ru@COFs, a ruthenium-based covalent organic framework material, was used to prepare antibacterial gel electrochemiluminescent devices by combining with sodium alginate, chitosan quaternary ammonium salt, triproamine and photosensitizer Ce6, and use flexible screen printing electrodes. And dual network hydrogels realize near-infrared electrochemiluminescence, drive photodynamic therapy, and avoid the use of physical light sources.

Benefits of technology

Achieving deeper and safer antibacterial effects, reducing surface skin damage, providing miniaturized wearable devices for integrated diagnosis and treatment, providing new methods for diabetic wound healing and bacterial monitoring.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909268A_ABST
    Figure CN118909268A_ABST
Patent Text Reader

Abstract

The invention provides a preparation method of a ruthenium-based covalent organic framework material, an antibacterial gel electrochemical luminescent device and application. According to the ruthenium-based covalent organic framework material Ru (at) COFs, accumulation of a tripropylamine co-reactant is promoted, and the reaction rate of the tripropylamine co-reactant and an intermediate is increased; the Ru (at) COFs disclosed by the invention emits stable high-intensity near-infrared light near 630nm, and the stable high-intensity near-infrared light can deeply penetrate through tissues and reduce surface skin injury; according to the antibacterial gel electrochemical light-emitting device, a large-area light-emitting device formed by combining the flexible screen-printed electrode and the double-network hydrogel is adopted, photodynamic therapy is driven through nano-limitation enhanced near-infrared electrochemical luminescence of Ru-coated COFs, and the deeper and safer antibacterial effect is achieved; according to the electrochemical luminescent device, the use of a physical light source is avoided, and a new example is provided for developing miniaturized wearable equipment for integrated diagnosis and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of electrochemiluminescent devices, and in particular relates to a preparation method of a ruthenium-based covalent organic framework material, an antibacterial gel electrochemiluminescent device and applications. Background Art

[0002] Wound healing in diabetic patients is a long and difficult process that is extremely susceptible to bacteria. The global spread of antibiotic resistance poses a major threat to public health. Compared with traditional antibiotic treatment, photodynamic therapy (PDT) has attracted much attention due to its spatiotemporal selectivity, non-invasive drug delivery and low resistance rate. PDT requires three key components: light, photosensitizer and oxygen. However, the need for external light sources hinders the portability and comfort of treatment devices, and there is an urgent need to develop internal light sources that can replace large physical light sources. Challenges in this field include the difficulty of miniaturizing the device due to the driving method and the limited penetration depth of the light source.

[0003] To address these challenges, researchers have attempted to use bioluminescence (BL), chemiluminescence (CL), electroluminescence (EL), and electrochemiluminescence (ECL) as excitation sources to drive PDT. Despite these significant advances, challenges such as low spatiotemporal resolution and difficulty in controlling the light emission process still hinder precise and controllable medical applications. The structure of existing ECL devices is usually composed of electrodes on both sides with an active layer sandwiched in the middle. The simple construction makes it suitable for low-cost and printable displays and solid-state light sources. However, the development of ECL in therapeutic applications is still restricted by problems such as driving mode limitations and limited penetration depth.

[0004] Based on the existing defects of current ECL devices, it is necessary to improve them. Summary of the invention

[0005] In view of this, the present invention proposes a ruthenium-based covalent organic framework material, an antibacterial gel electrochemiluminescent device and an application to solve the technical problems existing in the prior art.

[0006] In a first aspect, the present invention provides a method for preparing a ruthenium-based covalent organic framework material, comprising the following steps:

[0007] Will Ru(dcbpy) 3 2+ , 1,3,5-tri(4-aminophenyl)benzene and 2,5-dihydroxyterephthalic acid are added to a solvent and mixed, and then acetic acid is added. The mixture is allowed to stand for reaction, and a precipitate is separated and washed and dried to obtain a ruthenium-based covalent organic framework material.

[0008] Preferably, Ru(dcbpy) 3 2+Add to acetonitrile solvent to obtain Ru(dcbpy) 3 2+ Solution;

[0009] Adding 1,3,5-tris(4-aminophenyl)benzene to an acetonitrile solvent to obtain a 1,3,5-tris(4-aminophenyl)benzene solution;

[0010] Adding 2,5-dihydroxyterephthalic acid into acetonitrile solvent to obtain a 2,5-dihydroxyterephthalic acid solution;

[0011] Will Ru(dcbpy) 3 2+ The solution, 1,3,5-tri(4-aminophenyl)benzene solution and 2,5-dihydroxyterephthalic acid solution are mixed, ultrasonically dispersed, acetic acid is added, and the mixture is allowed to react at room temperature for 70 to 80 hours. The precipitate is separated, washed and dried to obtain a ruthenium-based covalent organic framework material.

[0012] Preferably, Ru(dcbpy) 3 2+ In the step of adding to the acetonitrile solvent, Ru(dcbpy) 3 2+ The molar volume ratio of the solvent to acetonitrile is (0.8-1.2) mmol: (3-5) mL;

[0013] In the step of adding 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent, the molar volume ratio of 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent is (0.02-0.06) mmol:(3-5) mL;

[0014] In the step of adding 2,5-dihydroxyterephthalic acid to the acetonitrile solvent, the molar volume ratio of 2,5-dihydroxyterephthalic acid to the acetonitrile solvent is (0.04-0.08) mmol: (3-5) mL;

[0015] The volume of the acetic acid is 1-2 mL, and the concentration is 10-15 mol / L.

[0016] In a second aspect, the present invention further provides an antibacterial gel electrochemiluminescent device, wherein the preparation method of the electrochemiluminescent device comprises the following steps:

[0017] Providing a substrate, wherein a working electrode, a counter electrode, and a reference electrode are arranged on the surface of the substrate;

[0018] Sodium alginate, chitosan quaternary ammonium salt, the ruthenium-based covalent organic framework material prepared by the preparation method, tripropylamine, and photosensitizer Ce6 are added to PBS buffer to obtain a gel precursor;

[0019] The gel precursor is coated on the surfaces of the working electrode, the counter electrode and the reference electrode, and the surface of the substrate and is located between the working electrode and the counter electrode, and between the working electrode and the reference electrode;

[0020] The substrate coated with the gel precursor is immersed in Ca 2+ In the solution, a cross-linking reaction occurs to obtain an antibacterial gel electrochemiluminescent device.

[0021] Preferably, the photosensitizer Ce6 is added to DMSO to prepare a photosensitizer solution, and then the photosensitizer solution is added to PBS buffer;

[0022] The mass volume ratio of the sodium alginate, chitosan quaternary ammonium salt, ruthenium-based covalent organic framework material, tripropylamine, photosensitizer solution, and PBS buffer is (0.3-0.5) g: (0.1-0.3) g: (4-8) mg: (18-21) μL: (8-12) μL: (8-12) mL;

[0023] The concentration of the photosensitizer solution is 8-12 mM.

[0024] Preferably, the Ca 2+ The solution is CaCl 2 solution, the Ca 2+ The mass concentration of the solution is 0.5-2%.

[0025] Preferably, a template is covered on the substrate, and the template is engraved with hollow patterns corresponding to the working electrode, the counter electrode, and the reference electrode;

[0026] Conductive ink is dropped onto the hollow pattern on the template, heated to evaporate the solvent in the conductive ink, and the template is removed to form a working electrode, a counter electrode, and a reference electrode on the substrate.

[0027] Preferably, the pH of the PBS buffer is 6.5-7;

[0028] The substrate is a polyvinyl chloride substrate.

[0029] In a third aspect, the present invention also provides an application of the antibacterial gel electrochemiluminescent device in antibacterial and bacteria counting.

[0030] In a fourth aspect, the present invention also provides the use of the antibacterial gel electrochemiluminescent device in the preparation of a wearable device for promoting diabetic wound healing.

[0031] The preparation method of a ruthenium-based covalent organic framework material, the antibacterial gel electrochemical luminescent device and the application of the present invention have the following beneficial effects compared with the prior art:

[0032] 1. The present invention uses covalent organic frameworks (COFs), a new type of low-toxic and stable porous material, to fix ruthenium and synthesize ruthenium-based covalent organic framework materials Ru@COFs, which promote the accumulation of tripropylamine (TPrA) co-reactants and accelerate the reaction rate with intermediates. The ruthenium-based covalent organic framework material Ru@COFs synthesized by the present invention emits stable high-intensity near-infrared light at around 630nm, which can penetrate tissues more deeply and reduce surface skin damage compared to the blue light of luminol;

[0033] 2. The antibacterial gel electrochemiluminescent device of the present invention can be used to treat diabetic wounds and monitor wound bacteria. The present invention adopts a large-area light-emitting device combining a flexible screen-printed electrode (SPE) with a double-network hydrogel, wherein PDT is driven by the nano-confined enhanced near-infrared electrochemiluminescence (ECL) of Ru@COFs to achieve a deeper and safer antibacterial effect. The customized-sized SPE inherits the inherent electrochemical sensing function and can bring reactive oxygen species into close contact with the wound. The electrochemiluminescent device avoids the use of physical light sources and provides a new paradigm for the development of miniaturized integrated diagnostic and therapeutic wearable devices. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0035] Figure 1 Schematic diagram of the preparation method of Ru@COFs and gel precursor of the present invention;

[0036] Figure 2 It is a schematic diagram of the preparation method of the antibacterial gel electrochemiluminescent device of the present invention;

[0037] Figure 3 This is a transmission electron microscope (TEM) image of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention;

[0038] Figure 4 This is a scanning electron microscope (SEM) image of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention;

[0039] Figure 5 This is a particle size distribution diagram of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention;

[0040] Figure 6The ECL spectrum test result diagram of the AGECLD prepared in Example 2 of the present invention and the GECLD prepared in Comparative Example 1;

[0041] Figure 7 The fluorescence spectra of AGECLD prepared in Example 2 of the present invention at different power supply times were tested using the ROS indicator DCFH;

[0042] Figure 8 This is a graph showing the in vitro antibacterial activity results of AGECLD prepared in Example 2 of the present invention;

[0043] Fig. 9 This is a graph showing the in vitro bacterial concentration determination curve of AGECLD prepared in Example 2 of the present invention. DETAILED DESCRIPTION

[0044] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0045] In order to better understand the present invention but not to limit the scope of the present invention, all the numbers used in this application to express the amount, percentage, and other numerical values ​​should be understood as modified by the word "about" in all cases. Therefore, unless otherwise specified, the numerical parameters listed in the specification and the appended claims are approximate values, which may be changed according to the different ideal properties attempted to be obtained. Each numerical parameter should at least be regarded as obtained based on the reported significant figures and by conventional rounding methods.

[0046] It should be noted that the order of description of the following embodiments is not intended to limit the preferred order of the embodiments. In addition, in the description of the present application, the term "including" means "including but not limited to". Various embodiments of the present invention may be in the form of a range; it should be understood that the description in the form of a range is only for convenience and brevity, and should not be understood as a rigid limitation on the scope of the present invention; therefore, it should be considered that the range description has specifically disclosed all possible sub-ranges and single numerical values ​​within the range. For example, it should be considered that the range description from 1 to 6 has specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as single numbers within the numbered range, such as 1, 2, 3, 4, 5 and 6, which applies regardless of the range. In addition, whenever a numerical range is indicated in this article, it is meant to include any cited numbers (fractions or integers) within the indicated range.

[0047] The present invention provides a method for preparing a ruthenium-based covalent organic framework material, comprising the following steps:

[0048] S1, Ru(dcbpy) 3 2+ (Tris(4,4-dicarboxybipyridyl)ruthenium chloride), 1,3,5-tris(4-aminophenyl)benzene (TPB), and 2,5-dihydroxyterephthalic acid (DHTP) are added to a solvent and mixed, and then acetic acid is added. The mixture is allowed to stand for reaction, and a precipitate is separated and washed and dried to obtain a ruthenium-based covalent organic framework material.

[0049] In order to enhance the intensity of the light source, the present invention uses covalent organic frameworks (COFs), a new type of low-toxic and stable porous material, to fix ruthenium and synthesize ruthenium-based covalent organic framework materials Ru@COFs, which promote the accumulation of tripropylamine (TPrA) co-reactants and accelerate the reaction rate with intermediates. The ruthenium-based covalent organic framework material Ru@COFs synthesized by the present invention emits stable high-intensity near-infrared light at around 630nm, which can penetrate tissues more deeply and reduce surface skin damage compared to the blue light of luminol.

[0050] In some embodiments, Ru(dcbpy) 3 2+ Add to acetonitrile solvent to obtain Ru(dcbpy) 3 2+ Solution;

[0051] Adding 1,3,5-tris(4-aminophenyl)benzene to an acetonitrile solvent to obtain a 1,3,5-tris(4-aminophenyl)benzene solution;

[0052] Adding 2,5-dihydroxyterephthalic acid into acetonitrile solvent to obtain a 2,5-dihydroxyterephthalic acid solution;

[0053] Will Ru(dcbpy) 3 2+ The solution, 1,3,5-tri(4-aminophenyl)benzene solution and 2,5-dihydroxyterephthalic acid solution are mixed, ultrasonically dispersed, acetic acid is added, and the mixture is allowed to react at room temperature for 70 to 80 hours. The precipitate is separated, washed and dried to obtain a ruthenium-based covalent organic framework material.

[0054] In some embodiments, Ru(dcbpy) 3 2+ In the step of adding to the acetonitrile solvent, Ru(dcbpy) 3 2+ The molar volume ratio of the solvent to acetonitrile is (0.8-1.2) mmol: (3-5) mL;

[0055] In the step of adding 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent, the molar volume ratio of 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent is (0.02-0.06) mmol:(3-5) mL;

[0056] In the step of adding 2,5-dihydroxyterephthalic acid to the acetonitrile solvent, the molar volume ratio of 2,5-dihydroxyterephthalic acid to the acetonitrile solvent is (0.04-0.08) mmol: (3-5) mL;

[0057] The volume of acetic acid is 1-2 mL and the concentration is 10-15 mol / L.

[0058] In some embodiments, a method for preparing a ruthenium-based covalent organic framework material comprises the following steps:

[0059] S1, 1mmol (Ru(dcbpy) 3 2+ (Tris(4,4-dicarboxybipyridyl)ruthenium chloride), 0.04mmol of 1,3,5-tris(4-aminophenyl)benzene (TPB) and 0.06mmol of 2,5-dihydroxyterephthalic acid (DHTP) were pre-loaded into three 5-mL centrifuge tubes, respectively, and then 3.3mL of acetonitrile solvent was added to each centrifuge tube and fully dissolved by vortex mixing and ultrasonication;

[0060] S2. Transfer the solutions in the three centrifuge tubes to 15 mL centrifuge tubes respectively and continue ultrasonic treatment to achieve uniform dispersion; then add 1.4 mL of acetic acid (12 mol / L) dropwise, gently shake the centrifuge tube, and immediately vortex mix it, and then seal it with a sealing film; after standing at room temperature for 72 hours, a large amount of orange precipitate can be observed; collect the precipitate by centrifugation at 8000 rpm for 3 minutes to obtain an orange product Ru@COFs, and then centrifuge and wash it with methanol for 3 times, and finally, vacuum dry the Ru@COFs product at 37°C for 48 hours to obtain an orange-yellow Ru@COFs powder, which is a ruthenium-based covalent organic framework material.

[0061] In order to enhance ECL-driven photodynamic therapy (PDT), the present invention adopts a method of limiting the mobility of the luminescent material and increasing its chance of interaction with the co-reactant, which leads to the synthesis of COF and Ru@COFs materials. The synthesis process is detailed in Figure 1 ; Characterization by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) showed that Ru@COFs were uniformly spherical with an average diameter of about 102 nanometers. The pore size of Ru@COFs was about 1.6 nanometers, which was suitable for Ru(dcbpy) 3 2+Powder X-ray diffraction (PXRD) analysis confirmed the crystallinity of COF and Ru@COFs, showing similar strong peaks at about 0.8°. Fourier transform infrared (FT-IR) spectroscopy showed the successful condensation reaction between amino and aldehyde groups in COF and Ru@COFs, as shown by the presence of -C=N peak.

[0062] Based on the same inventive concept, the present invention also provides an antibacterial gel electrochemiluminescent device, the preparation method of which comprises the following steps:

[0063] S1. Providing a substrate, wherein a working electrode, a counter electrode and a reference electrode are arranged on the surface of the substrate;

[0064] S2, adding sodium alginate (SA), chitosan quaternary ammonium salt (CQAS), ruthenium-based covalent organic framework material (Ru@COFs) prepared by the above preparation method, tripropylamine (TPrA), and photosensitizer Ce6 (dihydrochlorin e6) into PBS buffer to obtain a gel precursor;

[0065] S3, coating the gel precursor on the surfaces of the working electrode, the counter electrode and the reference electrode, as well as the surface of the substrate and between the working electrode and the counter electrode, and between the working electrode and the reference electrode;

[0066] S4, immersing the substrate coated with the gel precursor in Ca 2+ In the solution, a cross-linking reaction occurs to obtain an antibacterial gel electrochemiluminescent device.

[0067] Specifically, refer to Figure 1 As shown, it shows the preparation method of Ru@COFs and gel precursor; Figure 1 HAc represents acetic acid, and MeCN represents acetonitrile solvent; Figure 1 Photosensitizer Ce6 was also added during the preparation of the gel precursor.

[0068] In some embodiments, the photosensitizer Ce6 is added to DMSO (dimethyl sulfoxide) to prepare a photosensitizer solution, and then the photosensitizer solution is added to a PBS buffer.

[0069] In some embodiments, the mass volume ratio of sodium alginate, chitosan quaternary ammonium salt, ruthenium-based covalent organic framework material, tripropylamine, photosensitizer solution, and PBS buffer is (0.3-0.5) g: (0.1-0.3) g: (4-8) mg: (18-21) μL: (8-12) μL: (8-12) mL;

[0070] In some embodiments, the concentration of the photosensitizer solution is 8-12 mM, preferably 10 mM.

[0071] In some embodiments, Ca2+ The solution is CaCl 2 Solution (aqueous solution), Ca 2+ The mass concentration of the solution is 0.5-2%, preferably 1%.

[0072] In some embodiments, the substrate coated with the gel precursor is immersed in Ca 2+ In the solution, a cross-linking reaction occurs. There is no requirement for the temperature of the cross-linking reaction, and the reaction can be carried out at room temperature (25° C.).

[0073] In some embodiments, a template is covered on the substrate, and the template is engraved with hollow patterns corresponding to the working electrode, the counter electrode, and the reference electrode;

[0074] Conductive ink is dropped onto the hollow pattern on the template, heated to evaporate the solvent in the conductive ink, and the template is removed to form a working electrode, a counter electrode, and a reference electrode on the substrate.

[0075] In some embodiments, the pH of the PBS buffer is 6.5-7, preferably, the pH is 6.5, and the concentration is 0.1M.

[0076] In some embodiments, the substrate is a polyvinyl chloride substrate.

[0077] In some embodiments, according to the size of the wound, three-electrode shapes of different sizes suitable for the size of the wound are designed, and a hollow pattern corresponding to the three electrodes is carved on the template using a carving knife; the substrate actually used is a polyvinyl chloride (PVC) board, and a hollow sticker template engraved with the shape of the three electrodes is pasted on the adhesive surface of the polyvinyl chloride; a scraper is used to evenly apply the conductive ink so that it is coated on the hollow part of the PVC substrate; then, the substrate coated with the conductive ink is placed on a heating table, and the solvent in the conductive ink is allowed to completely evaporate at 40°C for 5 minutes; the sticker template is removed in a hot state, and a copper tape is introduced at the connection so that the crocodile clip can be connected on the workstation, thereby forming a screen-printed three-electrode (SPE) with good quality control.

[0078] For further reference, Figure 2 As shown, it shows the preparation method of the antibacterial gel electrochemiluminescent device of the present invention, covering a substrate 1 with a template 2, the template 2 is engraved with hollow patterns corresponding to the working electrode, the counter electrode, and the reference electrode, and dripping conductive ink on the hollow pattern on the template, heating to evaporate the solvent in the conductive ink, removing the template, that is, forming a working electrode 3, a counter electrode 4 and a reference electrode 5 on the substrate 1, and at the same time, connecting a copper tape 6 to the working electrode 3, the counter electrode 4 and the reference electrode 5; then coating a gel precursor on the surfaces of the working electrode, the counter electrode and the reference electrode, and the surface of the substrate and located between the working electrode and the counter electrode, and between the working electrode and the reference electrode, and then dripping Ca on the surface of the gel precursor 2+In the solution, a cross-linking reaction occurs to obtain an antibacterial gel electrochemiluminescent device.

[0079] Specifically, the conductive inks in the above embodiments are all commercially available conventional conductive inks for screen printing, for example, carbon-based conductive inks for screen printing.

[0080] The present invention develops a flexible electrochemiluminescent device (AGECLD) for monitoring and treating diabetic wounds; an integrated cross-linking method is used to seamlessly combine the conductive double network hydrogel with a customized-sized SPE, ensuring the stability of the wearable device and promoting the transmission of electrons and ions; the nano-confinement of Ru@COFs synergizes with the antibacterial chitosan drug treatment, enhancing the near-infrared ECL-driven PDT, making it deeper and safer; the electrochemiluminescent device (AGECLD) of the present invention shows excellent biocompatibility, high stability and antibacterial properties in vitro and in vivo, providing valuable diagnostic guidance for complex medical conditions.

[0081] Based on the same inventive concept, the present invention also provides an application of the above antibacterial gel electrochemiluminescent device in antibacterial and bacteria counting.

[0082] Based on the same inventive concept, the present invention also provides the use of the above-mentioned antibacterial gel electrochemiluminescent device in the preparation of a wearable device for promoting diabetic wound healing.

[0083] The present invention constructs an antibacterial gel electrochemiluminescent device (AGECLD) for antibacterial treatment and monitoring of diabetic wounds. The present invention quickly constructs a conductive double-network hydrogel through an integrated cross-linking method to form a bioelectrode-tissue interface for wearable devices, replacing the liquid system. In order to enhance the intensity of the light source, covalent organic frameworks (COFs), a new type of low-toxic and stable porous material, are used to fix ruthenium, promote the accumulation of tripropylamine (TPrA) co-reactants and accelerate the reaction rate with intermediates; the stable high-intensity near-infrared light emitted by Ru@COFs near 630nm can penetrate tissues more deeply and reduce surface skin damage compared to the blue light of luminol; the emission spectrum of ECL overlaps with the absorption spectrum of the photosensitizer dihydrochlorin e6 (Ce6), realizing energy transfer, and generating a large amount of ROS through the triplet excited state of Ce6 to fight bacteria; in the electrode part, the disposable screen-printed electrode (SPE) is based on The patterning of carbon paste modified polyvinyl chloride (PVC) can be customized in different sizes according to needs; this design applies a uniform electric field on a single-layer plane, overcomes the traditional sandwich structure, allows the release of drugs in the hydrogel, and can output electrochemical signals in real time in response to the bacterial concentration on the electrode surface to achieve wound management and priority intervention; the antibacterial gel electrochemiluminescent device (AGECLD) of the present invention exhibits good antibacterial and wound healing effects both in vivo and in vitro, providing a new way to develop PDT methods driven by internal light sources, and creating a new method for comprehensive point-of-care detection (POCT) of bacteria during diabetic wound treatment.

[0084] The following further describes the preparation method of the ruthenium-based covalent organic framework material, the antibacterial gel electrochemiluminescent device and the application of the present application with specific examples. This section further describes the content of the present invention in conjunction with specific examples, but should not be construed as limiting the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.

[0085] The conductive ink used in the following examples and comparative examples is screen-printed graphene ink. igsr00002 (provided by Delta Biotechnology Co., Ltd.);

[0086] The chitosan quaternary ammonium salt (CQAS) used in the following examples and comparative examples is 850126 chitosan quaternary ammonium salt, with a substitution degree of 98%, and a brand name: Macklin.

[0087] Example 1

[0088] This embodiment provides a method for preparing a ruthenium-based covalent organic framework material, comprising the following steps:

[0089] S1, 1mmol (Ru(dcbpy) 3 2+ (Tris(4,4-dicarboxybipyridyl)ruthenium chloride), 0.04mmol of 1,3,5-tris(4-aminophenyl)benzene (TPB) and 0.06mmol of 2,5-dihydroxyterephthalic acid (DHTP) were respectively placed in three 5 ml centrifuge tubes, and then 3.3mL of acetonitrile solvent was added to each centrifuge tube, and fully dissolved by vortex mixing and ultrasonication; Ru(dcbpy) 3 2+ solution, 1,3,5-tris(4-aminophenyl)benzene solution, 2,5-dihydroxyterephthalic acid solution;

[0090] S2. Will Ru(dcbpy) 3 2+ The solution, 1,3,5-tri(4-aminophenyl)benzene solution, and 2,5-dihydroxyterephthalic acid solution were transferred to a 15 mL centrifuge tube and continued to be ultrasonically treated to achieve uniform dispersion; then 1.4 mL of acetic acid (12 mol / L) was added dropwise, the centrifuge tube was shaken, and vortexed immediately for mixing, and then sealed with a sealing film; after standing at room temperature for 72 hours, a large amount of orange precipitate was observed; the precipitate was collected by centrifugation at 8000 rpm for 3 minutes to obtain an orange product Ru@COFs, which was then centrifuged and washed 3 times with methanol, and finally, the Ru@COFs product was vacuum dried at 37°C for 48 hours to obtain an orange-yellow Ru@COFs powder, which is a ruthenium-based covalent organic framework material.

[0091] Example 2

[0092] This embodiment provides an antibacterial gel electrochemiluminescent device, and the preparation method thereof comprises the following steps:

[0093] S1. Using a polyvinyl chloride plate as a substrate, a template with hollow patterns corresponding to the working electrode, the counter electrode, and the reference electrode is attached to the surface of the substrate;

[0094] S2. Apply conductive ink on the substrate at the corresponding hollow pattern, then place the substrate coated with conductive ink on a heating table to allow the solvent in the conductive ink to completely evaporate at 40°C for 5 minutes; remove the template in a hot state to form a working electrode, a counter electrode, and a reference electrode on the substrate; connect copper tapes to the working electrode, the counter electrode, and the reference electrode so that they can be connected to alligator clips on the workstation to form a screen-printed three-electrode (SPE) with good quality control;

[0095] S3, dissolving the photosensitizer Ce6 (dihydrochlorin e6) in 1 mL of DMSO to prepare a 10 mM photosensitizer solution;

[0096] 0.4 g of sodium alginate (SA), 0.2 g of chitosan quaternary ammonium salt (CQAS), 6 mg of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1, 19.6 μL of tripropylamine (TPrA), and 10 μL of photosensitizer solution were added to 10 mL of PBS buffer (pH 6.5, concentration 0.1 M) to obtain a gel precursor;

[0097] S4, apply 0.2mL of gel precursor on the surfaces of the working electrode, counter electrode, and reference electrode, as well as the substrate surface between the working electrode and the counter electrode, and between the working electrode and the reference electrode. The gel precursor coating area is 3.14cm 2 ;

[0098] S5. Soak the substrate coated with the gel precursor in a 1% CaCl 2 In the solution, a cross-linking reaction occurs at room temperature to obtain an antibacterial gel electrochemiluminescent device (denoted as AGECLD).

[0099] Comparative Example 1

[0100] This comparative example provides a gel electrochemiluminescent device, and its preparation method is the same as that of Example 2, except that no photosensitizer Ce6 is added in the process of preparing the gel precursor in step S3; specifically, the preparation method of the gel precursor in Comparative Example 1 specifically includes: adding 0.4g sodium alginate (SA), 0.2g chitosan quaternary ammonium salt (CQAS), 6mg ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1, and 19.6μL tripropylamine (TPrA) to 10mL PBS buffer (pH 6.5, concentration 0.1M) to obtain a gel precursor;

[0101] The remaining process steps are the same as those in Example 2, and the prepared gel electrochemiluminescent device is denoted as GECLD.

[0102] Comparative Example 2

[0103] This comparative example provides an electrochemiluminescent device, and its preparation method is the same as that of Example 2, except that chitosan quaternary ammonium salt (CQAS) is not added in the process of preparing the gel precursor in step S3; specifically, the preparation method of the gel precursor in Comparative Example 2 specifically includes: adding 0.4g sodium alginate (SA), 6mg ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1, 19.6μL tripropylamine (TPrA), and 10μL photosensitizer solution to 10mL PBS buffer (pH 6.5, concentration 0.1M) to obtain a gel precursor;

[0104] The remaining process steps are the same as those in Example 2.

[0105] Comparative Example 3

[0106] This comparative example provides an electrochemiluminescent device, and its preparation method is the same as that of Example 2, except that, in the process of preparing the gel precursor in step S3, Ru@COFs, tripropylamine (TPrA) and photosensitizer Ce6 are not added; specifically, the preparation method of the gel precursor in comparative example 3 specifically includes: adding 0.4g sodium alginate (SA) and 0.2g chitosan quaternary ammonium salt (CQAS) to 10mL PBS buffer (pH 6.5, concentration 0.1M) to obtain a gel precursor;

[0107] The remaining process steps are the same as those in Example 2.

[0108] Comparative Example 4

[0109] This comparative example provides an electrochemiluminescent device, and its preparation method is the same as that of Example 2, except that chitosan quaternary ammonium salt (CQAS), Ru@COFs, and tripropylamine (TPrA) are not added in the process of preparing the gel precursor in step S3; specifically, the preparation method of the gel precursor in Comparative Example 4 specifically includes: adding 0.4g sodium alginate (SA) and 10μL photosensitizer solution to 10mL PBS buffer (pH 6.5, concentration 0.1M) to obtain a gel precursor;

[0110] The remaining process steps are the same as those in Example 2.

[0111] Comparative Example 5

[0112] This comparative example provides an electrochemiluminescent device, and its preparation method is the same as that of Example 2, except that chitosan quaternary ammonium salt (CQAS), Ru@COFs, tripropylamine (TPrA), and photosensitizer Ce6 are not added in the process of preparing the gel precursor in step S3; specifically, the preparation method of the gel precursor in comparative example 5 specifically includes: adding 0.4 g of sodium alginate (SA) to 10 mL of PBS buffer (pH 6.5, concentration 0.1 M) to obtain a gel precursor;

[0113] The remaining process steps are the same as those in Example 2.

[0114] Performance characterization of Ru@COFs materials

[0115] Figure 3 This is a transmission electron microscope (TEM) image of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention; Figure 4 This is a scanning electron microscope (SEM) image of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention; Figure 5This is a particle size distribution diagram of the ruthenium-based covalent organic framework material Ru@COFs prepared in Example 1 of the present invention.

[0116] from Figures 3 to 5 It can be seen that the Ru@COFs prepared in the present invention present a uniform spherical shape with an average diameter of about 102 nanometers.

[0117] ECL Performance Evaluation

[0118] The AGECLD prepared in Example 2 and the GECLD prepared in Comparative Example 1 were placed on a microscope observation platform, and voltage was applied using an electrochemical workstation. At a voltage of 1.5 V, an electron multiplying charge coupled device (EMCCD, iXonUltra 888) was connected to a spectrometer (Kymera 193i), and the ECL spectrum under the microscope was captured to compare the intensity changes. The results are as follows: Figure 6 shown.

[0119] To achieve ECL-driven photodynamic therapy (PDT), it is critical to select a photosensitizer whose absorption peak is closely aligned with the ECL emission peak to ensure efficient ROS (reactive oxygen species) generation; preliminary examination of the ECL spectrum of GECLD using an electron multiplying ionization coupled device (EMCCD) ( Figure 6 A), a significant emission peak was found at 630 nm; Ce6 was selected as a photosensitizer because it has an optimal absorption peak at 650 nm; 10 μM Ce6 was integrated into the gel precursor to establish an antibacterial gel electrochemiluminescent device (AGECLD); the ECL spectra of GECLD and AGECLD were compared and evaluated, revealing that the ECL intensity decreased significantly after Ce6 incorporation, indicating ECL quenching.

[0120] Evaluation of AGECLD Active Oxygen Performance

[0121] To verify whether the quenching of ECL successfully excites Ce6 and triggers ROS generation, the reactive oxygen indicator DCFH (2',7'-dichlorodihydrofluorescein) is used as a fluorescent probe for measuring reactive oxygen. When encountering ROS, it is oxidized to 2',7'-dichlorofluorescein (DCF), emitting strong fluorescence, and the green fluorescence intensity is proportional to the level of reactive oxygen. According to the instructions, the reactive oxygen indicator DCFH is diluted to 1mM with the solvent DMSO and stored; it is diluted to 10μM using PBS buffer (pH 6.5, concentration 0.1M). The AGECLD in Example 2, its working electrode, counter electrode, and reference electrode are electrically connected to an electrochemical workstation (IviumSoft, CompactStat.h), and 10μM reactive oxygen indicator DCFH is dripped on the surface of the gel after the cross-linking reaction. A voltage of 1.5V is applied through the electrochemical workstation to promote ECL to emit light at 630nm, driving the photosensitizer Ce6 to produce ROS. The level of reactive oxygen species was measured using a fluorescence spectrophotometer with an excitation wavelength of 502 nm and an emission wavelength of approximately 530 nm.

[0122] The fluorescence spectra of the ROS indicator DCFH at different power-on times were tested. The results are as follows: Figure 7 As shown. Figure 7 As can be seen in the figure, the enhanced fluorescence value at 525 nm confirms the generation of strong oxidative ROS under the electric field. The ROS generation mechanism is related to the energy transfer from ECL generated by Ru@COFs to Ce6, which ultimately generates singlet oxygen (( 1 O 2 ), indicating that AGECLD has a strong ability for efficient ROS generation and has good therapeutic potential.

[0123] In vitro antibacterial activity of AGECLD

[0124] Staphylococcus aureus (S.aureus) was used as the experimental object, and the experiment was divided into 6 groups, with Group I as the control group, Group II using the electrochemiluminescent device prepared in Comparative Example 5, Group III using the electrochemiluminescent device prepared in Comparative Example 4, Group IV using the electrochemiluminescent device prepared in Comparative Example 3, Group V using the electrochemiluminescent device prepared in Comparative Example 2, and Group VI using the electrochemiluminescent device prepared in Example 2; 100 μL of Staphylococcus aureus solution was dripped onto the gel surface of the electrochemiluminescent devices of Groups II to VI, and the working electrode, counter electrode, and reference electrode were electrically connected to the electrochemical workstation, and the chronoamperometry was used to apply 30 cycles of 1.5V (10s) potential pulses and resting potential 0V (5s). 100uL of new LB liquid culture medium was taken to rinse the gel surface, and 200μL of bacterial solution was collected for each solution. 200μL of bacterial solution was inoculated into fresh 1mL Luria-Bertani (LB) liquid culture medium. The cells were cultured at 37°C with constant shaking for 12 h, coated and inoculated on LB solid culture medium, and coated and inoculated again at 37°C for 12 h. The bacterial survival rate was determined by colony counting; the Staphylococcus aureus liquid of Group I was not treated in any way.

[0125] The bacterial survival rate is calculated as follows:

[0126] Survival rate = C / C 0 ×100%;

[0127] In the formula, C 0 and C are the bacterial counts in the control group and experimental groups (Groups II to VI), respectively.

[0128] Specifically, the in vitro antibacterial effects of electrochemiluminescent devices prepared by different processes are as follows: Figure 8 As shown in A, the bacterial survival rate is Figure 8 As shown in B.

[0129] Compared with the control group, the photos of the agar plates showed that the antibacterial effect of CQAS was attributed to its high quaternary ammonium substitution effect; the SA+Ru@COFs+TPrA+Ce6+E group (i.e., Group V) showed effective antibacterial properties without relying on bulky external light sources, providing a flexible alternative to photodynamic therapy. The AGECLD+E treatment group (i.e., Group VI) showed a significant bactericidal effect of about 94% through combined photodynamic therapy and drug treatment. Figure 8The quantitative analysis of bacterial survival shown in B provides important insights into the efficacy of the bactericidal technique. (Thirty cycles of voltage controlled by chronoamperometry, from +1.5 V for 10 s to 0.0 V for 5 s). The resting potential was used to restore the amount of luminescent material on the electrode surface. Subsequently, the bacterial plates were incubated at 37°C over the course of 12 hours. The enhanced antibacterial effect from the AGECLD+E treatment group clearly shows the presence of the inhibition zone.

[0130] AGECLD bacteria count monitoring function

[0131] In the pursuit of enhancing therapeutic effects, there is considerable potential to integrate real-time monitoring capabilities into wearable devices. By enabling close physical contact and non-invasive data acquisition, the AGECLD of the present invention serves as a multifunctional tool. Notably, the negatively charged peptidoglycan layer on the surface of Staphylococcus aureus (S. aureus) interacts with the positively charged AGECLD surface, resulting in increased resistance of the bacteria through electrostatic interactions and reduced current due to nonspecific adhesion. Utilizing these unique properties, an electrochemical method for detecting bacterial concentrations was developed.

[0132] First, 200 μL of PBS buffer solution (pH=6.5) was dripped onto the gel surface of AGECLD prepared in Example 2 for stability test; the reference electrode, working electrode and counter electrode of the device were connected to the telephone line workstation interface respectively. The initial current signals of multiple electrodes were tested by chronoamperometry (applying 30 cycles of 1.5V (10s) potential pulses and resting potential 0V (5s)) to evaluate the stability. The cultured bacteria were centrifuged and the precipitate was dispersed in PBS with pH=6.5. The concentrations of 10 4 , 10 5 , 10 6 , 10 7 and 10 8 The experiment was conducted with a Staphylococcus aureus solution of 1.3 CFU / mL; using a biosensor based on Staphylococcus aureus, 200 μL of bacterial solution of each concentration was dripped onto the gel surface of AGECLD prepared in Example 2, and connected to an electrochemical workstation for testing (IviumSoft, CompactStat.h). When a periodic voltage is applied, after the current signal stabilizes, the current value is recorded and used to fit the linear correlation curve between the current change value (relative to the initial current) and the bacterial concentration. By drawing an analytical response curve of the target concentration in an appropriate form, the logarithmic value of the ΔI current change value and the bacterial concentration is obtained. The results are shown in Fig. 9 shown.

[0133] from Fig. 9 It can be seen that at 1.0×104 CFU / mL to 1.0×10 8 There is a positive correlation between CFU / mL, and the linear regression equation is ΔI=0.025lg c-0.018(R 2 =0.850). The calculated detection limit is about 1.0×10 3.5 CFU / mL, highlighting the potential of AGECLD for real-time monitoring of bacterial concentrations in vivo.

[0134] In summary, it can be seen from the above results that the AGECLD prepared by the present invention has excellent diagnostic and therapeutic effects, demonstrating its strength in promoting wound healing, antibacterial effects and clinical real-time bacterial count monitoring.

[0135] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a ruthenium-based covalent organic framework material, characterized in that: The following steps are involved: Will Ru(dcbpy)3 2+ , 1,3,5-tri(4-aminophenyl)benzene and 2,5-dihydroxyterephthalic acid are added to a solvent and mixed, and then acetic acid is added. The mixture is allowed to stand for reaction, and a precipitate is separated and washed and dried to obtain a ruthenium-based covalent organic framework material.

2. The method for preparing a ruthenium-based covalent organic framework material according to claim 1, characterized in that: Will Ru(dcbpy)3 2+ Add to acetonitrile solvent to obtain Ru(dcbpy)3 2+ Solution; Adding 1,3,5-tris(4-aminophenyl)benzene to an acetonitrile solvent to obtain a 1,3,5-tris(4-aminophenyl)benzene solution; Adding 2,5-dihydroxyterephthalic acid into acetonitrile solvent to obtain a 2,5-dihydroxyterephthalic acid solution; Will Ru(dcbpy)3 2+ The solution, 1,3,5-tri(4-aminophenyl)benzene solution and 2,5-dihydroxyterephthalic acid solution are mixed, ultrasonically dispersed, acetic acid is added, and the mixture is allowed to react at room temperature for 70 to 80 hours. The precipitate is separated, washed and dried to obtain a ruthenium-based covalent organic framework material.

3. The method for preparing a ruthenium-based covalent organic framework material according to claim 2, characterized in that: Will Ru(dcbpy)3 2+ In the step of adding to the acetonitrile solvent, Ru(dcbpy)3 2+ The molar volume ratio of the solvent to acetonitrile is (0.8-1.2) mmol: (3-5) mL; In the step of adding 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent, the molar volume ratio of 1,3,5-tris(4-aminophenyl)benzene to the acetonitrile solvent is (0.02-0.06) mmol:(3-5) mL; In the step of adding 2,5-dihydroxyterephthalic acid to the acetonitrile solvent, the molar volume ratio of 2,5-dihydroxyterephthalic acid to the acetonitrile solvent is (0.04-0.08) mmol: (3-5) mL; The volume of the acetic acid is 1-2 mL, and the concentration is 10-15 mol / L.

4. An antibacterial gel electrochemiluminescent device, characterized in that: The method for preparing the electrochemical luminescent device comprises the following steps: Providing a substrate, wherein a working electrode, a counter electrode, and a reference electrode are arranged on the surface of the substrate; Sodium alginate, chitosan quaternary ammonium salt, the ruthenium-based covalent organic framework material prepared by any one of the preparation methods described in claims 1 to 3, tripropylamine, and photosensitizer Ce6 are added to PBS buffer to obtain a gel precursor; The gel precursor is coated on the surfaces of the working electrode, the counter electrode and the reference electrode, and the surface of the substrate and is located between the working electrode and the counter electrode, and between the working electrode and the reference electrode; The substrate coated with the gel precursor is immersed in Ca 2+ In the solution, a cross-linking reaction occurs to obtain an antibacterial gel electrochemiluminescent device.

5. The antibacterial gel electrochemiluminescent device according to claim 4, characterized in that: The photosensitizer Ce6 was added to DMSO to prepare a photosensitizer solution, and then the photosensitizer solution was added to PBS buffer; The mass volume ratio of the sodium alginate, chitosan quaternary ammonium salt, ruthenium-based covalent organic framework material, tripropylamine, photosensitizer solution, and PBS buffer is (0.3-0.5) g: (0.1-0.3) g: (4-8) mg: (18-21) μL: (8-12) μL: (8-12) mL; The concentration of the photosensitizer solution is 8-12 mM.

6. The antibacterial gel electrochemiluminescent device according to claim 4, characterized in that: The Ca 2+ The solution is a CaCl2 solution, wherein the Ca 2+ The mass concentration of the solution is 0.5-2%.

7. The antibacterial gel electrochemiluminescent device according to claim 4, characterized in that: Covering the substrate with a template, wherein the template is engraved with hollow patterns corresponding to the working electrode, the counter electrode, and the reference electrode; Conductive ink is dropped onto the hollow pattern on the template, heated to evaporate the solvent in the conductive ink, and the template is removed to form a working electrode, a counter electrode, and a reference electrode on the substrate.

8. The antibacterial gel electrochemiluminescent device according to claim 4, characterized in that: The pH of the PBS buffer is 6.5-7; The substrate is a polyvinyl chloride substrate.

9. Use of the antibacterial gel electrochemiluminescent device as claimed in any one of claims 4 to 8 in antibacterial and bacteria counting.

10. Use of the antibacterial gel electrochemiluminescent device according to any one of claims 4 to 8 in preparing a wearable device for promoting diabetic wound healing.

Citation Information

Patent Citations

  • Preparation method and application of quenching-type electrochemiluminescence immunosensor made of MOF materials

    CN108918856A

  • Preparation method of label-free ECL (electrochemiluminescence) sensor for detecting estradiol on basis of self-luminescent material Ru@MOF-5

    CN109946289A

  • Fabrication method of Ru@MOF-5 dual-potential ratio-type electrogenerated chemiluminescence light-emitting sensor

    CN110441296A

  • Preparation method and application of electrochemiluminescence aptamer sensor

    CN113588752A

  • Preparation method and application of electrochemical luminescence activity fluorescence grading porous MOF (Metal Organic Framework)

    CN118185051A

Cited By

  • Wearable magnesium battery self-powered dressing for chronic wound healing and preparation method and application thereof

    CN120381549A